Home  >  Products  >  TREML2 (triggering receptor expressed on myeloid cells-like 2) Blocking Peptide (the N terminal of TREML2)(100ug)
TREML2 (triggering receptor expressed on myeloid cells-like 2) Blocking Peptide (the N terminal of TREML2)(100ug)

TREML2 (triggering receptor expressed on myeloid cells-like 2) Blocking Peptide (the N terminal of TREML2)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-TREML2 Antibody(ARP49877_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP49877
Size: 100ug
Weight: 41kDa
Gene: 79865
Format: Lyophilized powder
Target: TREML2 is a single-pass type I membrane protein, and it contains 1 Ig-like V-type (immunoglobulin-like) domain. TREML2 is a cell surface receptor that may play a role in the innate and adaptive immune response.
Alternative names: C6orf76; FLJ13693; MGC149715; MGC149716; TLT2; dJ238O23.1
See Full Product Listings >